Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin


Creative Commons License

AK G. , Tada Y., Shimada H., METİNTAŞ S. , Ito M., Hiroshima K., ...More

BMC CANCER, vol.17, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17
  • Publication Date: 2017
  • Doi Number: 10.1186/s12885-017-3209-5
  • Title of Journal : BMC CANCER
  • Keywords: Mesothelioma, Mesothelin, Midkine, Prognosis, Biomarker, PLEURAL MESOTHELIOMA, SOLUBLE MESOTHELIN, SERUM MESOTHELIN, HYALURONIC-ACID, OSTEOPONTIN, CANCER, BIOMARKER, UTILITY, GROWTH, METAANALYSIS

Abstract

Background: We evaluated possible diagnostic and prognostic values of serum midkine in malignant pleural mesothelioma in comparison with those of serum mesothelin, a well-established diagnostic biomarker.